Publicaciones Google Scholar de
1980 a
2022
| Título |
Fuente |
Fecha |
| Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice |
British Journal of Pharmacology , 2022 |
2022 |
| Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3, 4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon … |
Neuropharmacology 187, 108490 , 2021 |
2021 |
| Addiction and the kynurenine pathway: A new dancing couple? |
Pharmacology & Therapeutics 223, 107807 , 2021 |
2021 |
| Decreased kynurenine pathway potentiate resilience to social defeat effect on cocaine reward |
Neuropharmacology 197, 108753 , 2021 |
2021 |
| Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity |
Progress in Neuro-Psychopharmacology and Biological Psychiatry 102, 109958 , 2020 |
2020 |
| Changes in brain kynurenine levels via gut microbiota and gut‐barrier disruption induced by chronic ethanol exposure in mice |
The FASEB Journal 33 (11), 12900-12914 , 2019 |
2019 |
| Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients |
Scientific reports 9 (1), 1-11 , 2019 |
2019 |
| Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens |
Neuropharmacology 135, 581-591 , 2018 |
2018 |
| Serotonina y fármacos que actúan sobre el sistema serotoninérgico. Purinas |
Velázquez. Farmacología básica y clínica, 461-470 , 2018 |
2018 |
| 3, 4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus |
Neuropharmacology 118, 157-166 , 2017 |
2017 |
| Disruption of blood–brain barrier integrity in postmortem alcoholic brain: preclinical evidence of TLR4 involvement from a binge‐like drinking model |
Addiction biology 22 (4), 1103-1116 , 2017 |
2017 |
| SY21 BIOMARKERS AND DRUG TARGETS IN ALCOHOL ABUSE AND DEPENDENCE SY21-1 INCREASE IN BLOOD-BRAIN BARRIER PERMEABILITY IN POST-MORTEM ALCOHOLIC BRAIN: INVOLVEMENT OF TLR4 |
Alcohol and Alcoholism 50 (suppl_1), i24-i24 , 2015 |
2015 |
| INCREASE IN BLOOD-BRAIN BARRIER PERMEABILITY IN POST-MORTEM ALCOHOLIC BRAIN: INVOLVEMENT OF TLR4 |
ALCOHOL AND ALCOHOLISM 50 , 2015 |
2015 |
| Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine |
Neuropharmacology 87, 125-134 , 2014 |
2014 |
| The JNK inhibitor, SP600125, potentiates the glial response and cell death induced by methamphetamine in the mouse striatum |
International Journal of Neuropsychopharmacology 17 (2), 235-246 , 2014 |
2014 |
| Effect of intensive and repeated use of ethanol on the integrity of blood-brain barrier in mouse brain. Role of toll-like receptor 4 (TLR4) |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 41-41 , 2014 |
2014 |
| EFFECT OF MDMA ON AQP4 EXPRESSION IN ASTROCYTIC ENDFEET AND TPA ACTIVITY IN RAT HIPPOCAMPUS |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 42-42 , 2014 |
2014 |
| 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X 7 receptors |
International Journal of Neuropsychopharmacology 17 (8), 1243-1255 , 2014 |
2014 |
| A study on the effect of JNK inhibitor, SP600125, on the disruption of blood–brain barrier induced by methamphetamine |
Neurobiology of disease 50, 49-58 , 2013 |
2013 |
| Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders |
Psychopharmacology 230 (1), 125-135 , 2013 |
2013 |
| Implicación de la molécula de adhesión ALCAM en el daño cerebral: modelo de daño neuronal mediante la administración de MDMA/éxtasis en rata |
Trauma 24 (2), 101-108 , 2013 |
2013 |
| Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine |
Neurobiology of disease 45 (2), 810-820 , 2012 |
2012 |
| Changes in the serotonergic system and in brain-derived neurotrophic factor distribution in the main olfactory bulb of pcd mice before and after mitral cell loss |
Neuroscience 201, 20-33 , 2012 |
2012 |
| INNOVATIONS IN PHARMACOLOGY EVALUATION: PILOT STUDY ON THE PARTICIPATION OF STUDENTS IN" FUNDAMENTOS DE FARMACOLOGIA EN FISIOTERAPIA'' |
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 109, 28-28 , 2011 |
2011 |
| Changes in interleukin-1 signal modulators induced by 3, 4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity |
Journal of Neuroinflammation 8 (1), 1-14 , 2011 |
2011 |
| PRECLININCAL AND CLINICAL STUDIES ON THE INTERACTION OF MDMA WITH OTHER RECREATIONAL DRUGS |
JOURNAL OF PSYCHOPHARMACOLOGY 25 (8), A1-A1 , 2011 |
2011 |
| Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA |
Journal of Neuroinflammation 8 (1), 1-11 , 2011 |
2011 |
| Dopamine transporter down‐regulation following repeated cocaine: implications for 3, 4‐methylenedioxymethamphetamine‐induced acute effects and long‐term neurotoxicity in mice |
British journal of pharmacology 159 (1), 201-211 , 2010 |
2010 |
| Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration |
Neurotoxicity research 18 (1), 48-58 , 2010 |
2010 |
| Evidence that MDMA (‘ecstasy’) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain |
Journal of neurochemistry 113 (1), 67-78 , 2010 |
2010 |
| Involvement of 2‐arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine |
British journal of pharmacology 160 (3), 772-783 , 2010 |
2010 |
| A study on the mechanisms by which minocycline protects against MDMA (‘ecstasy’)-induced neurotoxicity of 5-HT cortical neurons |
Neurotoxicity research 18 (2), 187-199 , 2010 |
2010 |
| Sex-dependent maternal deprivation effects on brain monoamine content in adolescent rats |
Neuroscience letters 479 (2), 112-117 , 2010 |
2010 |
| Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum |
Psychopharmacology 207 (4), 671-679 , 2010 |
2010 |
| Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement |
International Journal of Neuropsychopharmacology 12 (7), 929-940 , 2009 |
2009 |
| Early loss of dopaminergic terminals in striosomes after MDMA administration to mice |
Synapse 62 (1), 80-84 , 2008 |
2008 |
| Éxtasis líquido: estructura, farmacología, efectos adversos y mecanismos de acción |
Trastornos Adictivos 10 (3), 190-194 , 2008 |
2008 |
| Evidence that JWH015 (CB (2) agonist) reduces MDMA-induced neuroinflammation but fails to provide protection |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 22, 70-70 , 2008 |
2008 |
| Neurotoxic doses of METH increase ethanol consumption and preference: Involvement of endocannabinoid system |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 22, 70-70 , 2008 |
2008 |
| Cocaine withdrawal internalizes DAT in the endosome and prevents MDMA-induced dopaminergic toxicity in mouse striatum |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 22, 89-89 , 2008 |
2008 |
| Effect of ethanol on GABA turnover in the brain of mice treated with a neurotoxic dose of MDMA |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 22, 88-89 , 2008 |
2008 |
| Persistent MDMA‐induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice |
Journal of neurochemistry 107 (4), 1102-1112 , 2008 |
2008 |
| Éxtasis líquido: estudios neurobiológicos en el laboratorio |
Trastornos Adictivos 10 (3), 195-200 , 2008 |
2008 |
| Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA exhibit increased ethanol consumption and preference |
Journal of Pharmacology and Experimental Therapeutics , 2007 |
2007 |
| Factors contributing to the enhancement of MDMA-induced 5-HT depletion by ethanol: a reply to Byron and Cassel |
Psychopharmacology 190 (4), 581-582 , 2007 |
2007 |
| Hsp70 and MDMA neurotoxicity |
Journal of neurochemistry , 2007 |
2007 |
| Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3, 4‐methylenedioxymethamphetamine toxicity in rat brain |
Journal of neurochemistry 101 (5), 1272-1283 , 2007 |
2007 |
| Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain |
Psychopharmacology 189 (4), 459-470 , 2007 |
2007 |
| MDMA and Other “Club Drugs” |
Handbook of Contemporary Neuropharmacology , 2007 |
2007 |
| NEUROPHARMACOLOGY-Mice with Decreased Cerebral Dopamine Function following a Neurotoxic Dose of MDMA (3, 4-Methylenedioxymethamphetamine," Ecstasy") Exhibit Increased Ethanol … |
Journal of Pharmacology and Experimental Therapeutics 322 (3), 1003-1012 , 2007 |
2007 |
| Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA (3, 4-methylenedioxymethamphetamine,“Ecstasy”) exhibit increased ethanol consumption and … |
Journal of Pharmacology and Experimental Therapeutics 322 (3), 1003-1012 , 2007 |
2007 |
| 6.2. Alucinógenos, anfetaminas y drogas de síntesis. 6.2. 1. Bases biológicas |
Tratado SET de Trastornos Adictivos, 181-187 , 2006 |
2006 |
| MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature |
British journal of pharmacology 148 (6), 778-785 , 2006 |
2006 |
| A comparative study on the acute and long‐term effects of MDMA and 3, 4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after ip or striatal administration in mice |
British journal of pharmacology 144 (2), 231-241 , 2005 |
2005 |
| The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature |
Psychopharmacology 179 (4), 884-890 , 2005 |
2005 |
| Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats |
Neuropsychopharmacology 30 (7), 1312-1323 , 2005 |
2005 |
| 3, 4-Methylenedioxymethamphetamine increases pro-interleukin-1β production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: Role … |
Neuroscience 135 (4), 1095-1105 , 2005 |
2005 |
| Studies on the effect of MDMA (ecstasy) on the body temperature of rats housed at different ambient room temperatures. |
Nature Publishing Group , 2005 |
2005 |
| The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature. |
Springer Verlag , 2005 |
2005 |
| Studies on heat loss by the tails of rats administered a neurotoxic dose of MDMA |
JOURNAL OF PSYCHOPHARMACOLOGY 19 (5), A26-A26 , 2005 |
2005 |
| Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures |
British journal of pharmacology 146 (2), 306-312 , 2005 |
2005 |
| A comparative study of the brain monoamine changes induced by intrastriatal or peripheral administration of MDMA and DHMA to mice |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 149-149 , 2004 |
2004 |
| Changes induced by MDMA in pro-IL-1 beta levels in rat brain and influence of ambient room temperature |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 90-90 , 2004 |
2004 |
| Éxtasis y cerebro |
XXVI Congreso SEBBM, A Coruña 16-18 de septiembre 2003: mesas redondas de … , 2004 |
2004 |
| New targets for preventing MDMA neurotoxicity in rats |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 13-13 , 2004 |
2004 |
| Serotonin and MDMA-induced hyperthermia |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 133-133 , 2004 |
2004 |
| Effect of ambient temperature and a prior neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge … |
Psychopharmacology 173 (3), 264-269 , 2004 |
2004 |
| MDMA-is serotonin the only target for neurotoxicity? |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A7-A7 , 2004 |
2004 |
| The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test |
Pharmacology Biochemistry and Behavior 77 (4), 805-814 , 2004 |
2004 |
| Long-lasting brain 5-HT deficits induced by a single MDMA administration to dark Agouti rats |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A39-A39 , 2004 |
2004 |
| Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function |
Psychopharmacology 173 (3), 249-263 , 2004 |
2004 |
| Decreased 5-HT function following a neurotoxic dose of MDMA results in impaired thermoregulation |
Journal of Psychopharmacology 18 (3), A38-A38 , 2004 |
2004 |
| 3, 4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletion |
Journal of neurochemistry 89 (6), 1445-1453 , 2004 |
2004 |
| 3, 4-Methylenedioxymethamphetamine (MDMA,'ecstasy') activates microglia in rat brain by a process not dependent on hyperthermia |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 120-120 , 2004 |
2004 |
| Serotonina y fármacos antiserotoninérgicos. Purinas |
Velázquez. Farmacología Básica y Clínica, 477-485 , 2004 |
2004 |
| A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response |
European journal of pharmacology 500 (1-3), 3-13 , 2004 |
2004 |
| Role of interleukin-1 beta in the acute and long-term effects of MDMA |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 133-133 , 2004 |
2004 |
| An elevation of ambient room temperature enhances the MDMA-induced dopamine and 5-HT release in the nucleus accumbens but not in the striatum of rats |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 123-123 , 2004 |
2004 |
| MDMA metabolism: Source of neuroactive compounds |
JOURNAL OF PSYCHOPHARMACOLOGY 18 (3), A7-A7 , 2004 |
2004 |
| Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones |
Journal of psychopharmacology 18 (3), 412-416 , 2004 |
2004 |
| Heat pretreatment increases MDMA-induced heat shock protein 70 expression in the rat cortex but does not protect against 5-HT neurodegeneration |
FUNDAMENTAL & CLINICAL PHARMACOLOGY 18, 150-150 , 2004 |
2004 |
| Effects of MDMA pretreatment upon drug reward. |
Psychopharmacology 166 (4) , 2003 |
2003 |
| Sustained MDMA-induced inhibition of tryptophan hydroxylase activity leads to the long-term cerebral 5-HT loss |
BRITISH JOURNAL OF PHARMACOLOGY 140 , 2003 |
2003 |
| Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse |
Psychopharmacology 166 (4), 383-390 , 2003 |
2003 |
| Intracerebroventricular interleukin-1 beta exacerbates MDMA-induced neurotoxicity by an additive effect on rectal temperature |
BRITISH JOURNAL OF PHARMACOLOGY 140 , 2003 |
2003 |
| Is frequent dosing with ecstasy a risky business for dopamine-containing neurons? |
Trends in pharmacological sciences 24 (6), 272-274 , 2003 |
2003 |
| Evidence that MDMA ('ecstasy') increases interleukin-1 beta levels in rat brain |
BRITISH JOURNAL OF PHARMACOLOGY 140 , 2003 |
2003 |
| Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats |
Neuropharmacology 44 (4), 449-461 , 2003 |
2003 |
| Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy) |
Brain research 987 (2), 144-154 , 2003 |
2003 |
| The nNOS inhibitor, AR‐R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum |
Journal of neurochemistry 85 (2), 515-524 , 2003 |
2003 |
| Formation of glutathione adduct metabolites of MDA in human liver microsomes is related to CYP2D6 activity |
BRITISH JOURNAL OF PHARMACOLOGY 138, U97-U97 , 2003 |
2003 |
| Neurobiología del éxtasis |
Ibérica: Actualidad tecnológica, 520-526 , 2003 |
2003 |
| On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor |
Psychopharmacology 165 (3), 317-319 , 2003 |
2003 |
| The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”) |
Pharmacological reviews 55 (3), 463-508 , 2003 |
2003 |
| Methamphetamine induces a long term loss of neurofilament protein NF68 in mouse striatum |
BRITISH JOURNAL OF PHARMACOLOGY 135 , 2002 |
2002 |
| Protection against 3, 4‐methylenedioxymethamphetamine‐induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia |
Journal of neurochemistry 81 (4), 686-695 , 2002 |
2002 |
| Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced … |
Journal of neurochemistry 81 (5), 961-972 , 2002 |
2002 |
| Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance |
Journal of Cerebral Blood Flow & Metabolism 22 (11), 1297-1302 , 2002 |
2002 |
| A selenium deficient diet potentiates the long term loss of striatal dopamine induced by MDMA in mice and induces depletion of cortical 5-HT |
British Journal of Pharmacology 135 , 2002 |
2002 |
| The pharmacology of the acute hyperthermic response that follows administration of 3, 4‐methylenedioxymethamphetamine (MDMA,‘ecstasy’) to rats |
British journal of pharmacology 135 (1), 170-180 , 2002 |
2002 |
| Abstracts-Role of Glutathione in 3, 4-Methylenedioxymethamphetamine-Induced Neurodegeneration in Dark Agouti Rats |
Proceedings of the Western Pharmacology Society 44, 258 , 2001 |
2001 |
| Prevention of 3, 4-methylenedioxymethamphetamine (MDMA, ECSTASY) induced neurodegeneration by the clomethiazole analogue Ar-A008055 |
BRITISH JOURNAL OF PHARMACOLOGY 133, U70-U70 , 2001 |
2001 |
| Abstracts-The Synthesis and Purification of 5-(Glutathion-S-yl)-(a-Methyidopamine and Formation of a Structurally Related GSH Regioisomer |
Proceedings of the Western Pharmacology Society 44, 255-255 , 2001 |
2001 |
| Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain |
Neuropharmacology 40 (1), 65-74 , 2001 |
2001 |
| Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA (" ecstasy")-induced neurodegeneration in rat … |
Psychopharmacology 157 (1), 82-88 , 2001 |
2001 |
| A neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation |
Psychopharmacology 155 (4), 413-418 , 2001 |
2001 |
| 3, 4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected … |
Psychopharmacology 154 (3), 251-260 , 2001 |
2001 |
| EFECTO NEUROTOXICO DE MDMA (" extasis") SOBRE LOS TERMINALES SEROTONINERGICOS TRAS SU ADMINISTRACION INTRACEREBRAL DIRECTA, COMPARACION CON 5, 7-DHT |
ADICCIONES-PALMA DE MALLORCA- 12, 59-59 , 2000 |
2000 |
| EFECTO DE GBR 12,909 SOBRE LA PERDIDA DE DOPAMINA A CORTOY LARGO PLAZO INDUCIDA POR LA ADMINISTRACION REPETIDA DE MDMA (" extasis") FN RATON |
ADICCIONES-PALMA DE MALLORCA- 12, 95-95 , 2000 |
2000 |
| Effects of neurotensin on cognitive behaviour and brain neurotransmitter amines |
EUROPEAN JOURNAL OF NEUROSCIENCE 12, 96-96 , 2000 |
2000 |
| Effect of 7-nitroindazole on the hypothermia and the striatal dopamine loss induced by MDMA in mice |
BRITISH JOURNAL OF PHARMACOLOGY 127, U40-U40 , 1999 |
1999 |
| Similar brain concentrations of MDMA have different neurotoxic effects following central or peripheral drug administration |
British Journal of Pharmacology 127, U40-U40 , 1999 |
1999 |
| Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration |
Psychopharmacology 142 (4), 421-425 , 1999 |
1999 |
| In vivo evidence against clomethiazole being neuroprotective against MDMA (‘ecstasy’)-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism |
Neuropharmacology 38 (2), 307-314 , 1999 |
1999 |
| NEUROPHARMACOLOGY-Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3, 4-methylenedioxymethamphetamine (MDMA … |
British Journal of Pharmacology 126 (4), 911-924 , 1999 |
1999 |
| The Acute Effect in Rats of 3, 4‐Methylenedioxyethamphetamine (MDEA,“Eve”) on Body Temperature and Long Term Degeneration of 5‐HT Neurones in Brain: A Comparison with MDMA … |
Pharmacology & toxicology 84 (6), 261-266 , 1999 |
1999 |
| Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3, 4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy … |
British journal of pharmacology 126 (4), 911-924 , 1999 |
1999 |
| Further evidence that NMDA antagonists against MDMA ('ecstasy')-induced neurodegeneration because of hypothermia |
BRITISH JOURNAL OF PHARMACOLOGY 123, U149-U149 , 1998 |
1998 |
| Implicación de los radicales libres en la neurodegeneración inducida por 3, 4-metilenodioximetanfetamina (MDMA) |
Universidad Complutense de Madrid , 1998 |
1998 |
| Evidence against clomethiazole preventing MDMA-induced neurodegeneration by free radical scavenging |
British Journal of Pharmacology-Proceedings Supplement, 43P , 1998 |
1998 |
| Role of body temperature in the protective action of haloperidol against MDMA-induced neurodegeneration |
British Journal of Pharmacology-Proceedings Supplement, 44P , 1998 |
1998 |
| The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (ecstasy') |
Neuropharmacology 37 (7), 919-926 , 1998 |
1998 |
| Further evidence that NMDA antagonists protect against MDMA ('ecstasy')-induced neurodegeneration because of hypothermia |
British Journal of Pharmacology-Proceedings Supplement, 259P , 1998 |
1998 |
| Role of hyperthermia in the protective action of clomethiazole against MDMA (‘ecstasy’)‐induced neurodegeneration, comparison with the novel NMDA channel blocker AR‐R15896AR |
British journal of pharmacology 124 (3), 479-484 , 1998 |
1998 |
| The role of temperature in the neuroprotective effect of clomethiazole against MDMA-induced degeneration in rat brain |
British Journal of Pharmacology-Proceedings Supplement, 304P , 1997 |
1997 |
| A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy |
British Journal of Pharmacology 121 (4), 827-833 , 1997 |
1997 |
| Relationship between the dose of MDMA and frequency of administration on the subsequent neurodegeneration of rat brain 5-HT |
British Journal of Pharmacology-Proceedings Supplement, 303P , 1997 |
1997 |
| In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p ‐chloroamphetamine but not … |
British journal of pharmacology 121 (5), 889-900 , 1997 |
1997 |
